Altered memory T-cell responses to Bacillus Calmette-Guerin and Tetanus Toxoid vaccination and altered cytokine responses to polyclonal stimulation in HIV-exposed uninfected Kenyan infants

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Garcia Knight, Miguel A ^a,b   Nduati, Eunice ^b   Hassan, Amin S ^b   Gambo, Faith ^b   Odera, Dennis ^b   Etyang, Timothy J ^b   Hajj, Nassim J ^c   Berkley, James Alexander ^a,b   Urban, Britta C ^b,d   Rowland Jones, Sarah L ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^c Kilifi District Hospital   (Kenya)

^d LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BCG VACCINE; INTERLEUKIN 2; MYCOBACTERIUM TUBERCULOSIS ANTIGEN; STAPHYLOCOCCUS ENTEROTOXIN B; TETANUS TOXOID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE;

AGE DISTRIBUTION; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOKINE RESPONSE; DISEASE MARKER; DRUG EFFICACY; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; HIV EXPOSED UNIFECTED; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREACTIVITY; IN VIVO STUDY; INFANT; KENYAN; LONG TERM CARE; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MEMORY T LYMPHOCYTE; NONHUMAN; PATIENT MONITORING; PHENOTYPE; POLYCLONAL ACTIVATION; POPULATION EXPOSURE; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; VIRUS LOAD; ADAPTIVE IMMUNITY; CD4 CD8 RATIO; HIV INFECTIONS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; KENYA; MALE; METABOLISM; MICROBIOLOGY; PREVENTION AND CONTROL; SECRETION (PROCESS); TRANSMISSION; VACCINATION; VERTICAL TRANSMISSION;

ADAPTIVE IMMUNITY; BCG VACCINE; CD4-CD8 RATIO; CROSS-SECTIONAL STUDIES; CYTOKINES; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOLOGIC MEMORY; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; KENYA; MALE; TETANUS TOXOID; TH1 CELLS; VACCINATION;

EID: 84957110193     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0143043     Document Type: Article

References (55)

1. Mahy M, Stover J, Kiragu K, Hayashi C, Akwara P, Luo C, et al. What will it take to achieve virtual elimination of mother-to-child transmission of HIV? An assessment of current progress and future needs. Sex Transm Infect. 2010; 86(Suppl 2):ii48-55. doi: 10.1136/sti.2010.045989 PMID: 21106515
2. Mofenson LM. New Challenges in the Elimination of Pediatric HIV Infection: The Expanding Population of HIV-Exposed but Uninfected Children. Clin Infect Dis. 2015; 60(9):1357-60. doi: 10.1093/cid/civ064 PMID: 25645210
3. Slogrove A, Reikie B, Naidoo S, De Beer C, Ho K, Cotton M, et al. HIV-Exposed Uninfected Infants are at Increased Risk for Severe Infections in the First Year of Life. J Trop Pediatr. 2012 May 3; 58(6):505-8. doi: 10.1093/tropej/fms019 PMID: 22555385
4. Von Mollendorf C, von Gottberg a., Tempia S, Meiring S, de Gouveia L, Quan V, et al. Increased risk and mortality of invasive pneumococcal disease in HIV-exposed-uninfected infants <1 year of age in South Africa, 2009-2013. Clin Infect Dis. 2015 Feb 2; 60(5):1346-56.
5. Koyanagi A, Humphrey JH, Ntozini R, Nathoo K, Moulton LH, Iliff P, et al. Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy. Pediatr Infect Dis J. 2011; 30(1):45-51. doi: 10.1097/INF.0b013e3181ecbf7e PMID: 21173675
6. Shapiro RL, Lockman S. Mortality among HIV-exposed infants: the first and final frontier. Clin Infect Dis. 2010 Mar 1; 50(3):445-7. doi: 10.1086/649887 PMID: 20047482
7. Afran L, Garcia Knight M, Nduati E, Urban BC, Heyderman RS, Rowland-Jones SL. HIV-exposed uninfected children: a growing population with a vulnerable immune system? Clin Exp Immunol. 2014 Apr; 176(1):11-22. doi: 10.1111/cei.12251 PMID: 24325737
8. Jones CE, Naidoo S, De Beer C, Esser M, Kampmann B, Hesseling AC. Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA. 2011 Feb 9; 305(6):576-84. doi: 10.1001/jama.2011.100 PMID: 21304083
9. Cumberland P, Shulman CE, Maple PAC, Bulmer JN, Dorman EK, Kawuondo K, et al. Maternal HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya. J Infect Dis. 2007 Aug 15; 196(4):550-7. PMID: 17624840
10. Le Chenadec J, Mayaux M-J, Guihenneuc-Jouyaux C, Blanche S, Group for the EPFS. Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants. Aids. 2003; 17(14):2053-61. PMID: 14502008
11. Bunders M, Thorne C, Newell ML. Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-1-infected mothers. Aids. 2005; 19(10):1071-9. PMID: 15958839
12. European Collaborative Study. Levels and patterns of neutrophil cell counts over the first 8 years of life in children of HIV-1-infected mothers. Aids. 2004; 18(15):2009-17. PMID: 15577622
13. Ono E, Nunes dos Santos AM, de Menezes Succi RC, Machado DM, de Angelis DS, Salomão R, et al. Imbalance of naive and memory T lymphocytes with sustained high cellular activation during the first year of life from uninfected children born to HIV-1-infected mothers on HAART. Braz J Med Biol Res. 2008 Aug; 41(8):700-8. PMID: 18797705
14. Clerici M, Saresella M, Colombo F, Fossati S, Sala N, Bricalli D, et al. T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood. 2000; 96(12):3866-71. PMID: 11090071
15. Rowland-Jones SL, Nixon DF, Aldhous MC, Gotch F, Ariyoshi K, Hallam N, et al. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet. 1993 Apr 3; 341(8849):860-1. PMID: 8096564
16. Cheynier R, Langlade-Demoyen P, Marescot MR, Blanche S, Blondin G, Wain-Hobson S, et al. Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers. Eur J Immunol. 1992 Sep; 22(9):2211-7. PMID: 1381309
17. Legrand FA, Nixon DF, Loo CP, Ono E, Chapman JM, Miyamoto M, et al. Strong HIV-1-Specific T Cell Responses in HIV-1-Exposed Uninfected Infants and Neonates Revealed after Regulatory T Cell Removal. PLoS One. 2006 Jan; 1(1):e102.
18. Sanz-Ramos M, Manno D, Kapambwe M, Ndumba I, Musonda KG, Bates M, et al. Reduced Poliovirus vaccine neutralising-antibody titres in infants with maternal HIV-exposure. Vaccine. 2013 Apr 12; 31 (16):2042-9. doi: 10.1016/j.vaccine.2013.02.044 PMID: 23474309
19. Nduati E, Hassan A, Garcia-Knight M, Muema D, Jahangir M, Mwaringa S, et al. Outcomes of prevention of mother to child transmission of the human immunodeficiency virus-1 in rural Kenya - A cohort study. BMC Public Health. In press
20. National AIDS and STI Control Programme. Guidelines for antiretroviral therapy in Kenya. 2011. Available: http://healthservices.uonbi.ac.ke/sites/default/files/centraladmin/healthservices/Kenya% 20Treatment%20Guidelines%202011.pdf
21. World Health Organization. Antiretroviral Drugs For Treating Pregnant Women and Preventing HIV Infection in Infants: Recommendations for a Public Health Approach. Geneva: WHO. 2010;
22. Kimanga DO, Ogola S, Umuro M, Ng'ang'a A, Kimondo L, Murithi P, et al. Prevalence and incidence of HIV infection, trends, and risk factors among persons aged 15-64 years in Kenya: results from a nationally representative study. J Acquir Immune Defic Syndr. 2014 May 1; 66 Suppl 1:S13-26. doi: 10.1097/QAI.0000000000000124 PMID: 24445338
23. National AIDS and STI Control Programme. Kenya HIV estimates report 2014. 2014. Available: http://www.nacc.or.ke/attachments/article/428/HIV estimates report Kenya 2014-print.pdf
24. Rouet F, Chaix M-L, Nerrienet E, Ngo-Giang-Huong N, Plantier J-C, Burgard M, et al. Impact of HIV-1 genetic diversity on plasma HIV-1 RNA Quantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test. J Acquir Immune Defic Syndr. 2007 Aug 1; 45(4):380-8. PMID: 17468666
25. Rich KC, Siegel JN, Jennings C, Rydman RJ, Landay AL. Function and phenotype of immature CD4+ lymphocytes in healthy infants and early lymphocyte activation in uninfected infants of human immunodeficiency virus-infected mothers. Clin Diagn Lab Immunol. 1997 May; 4(3):358-61. PMID: 9144377
26. HanekomWa, Hughes J, Mavinkurve M, Mendillo M, Watkins M, Gamieldien H, et al. Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies. J Immunol Methods. 2004 Aug; 291(1-2):185-95. PMID: 15345316
27. Roederer M, Nozzi JL, Nason MC. SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A. 2011 Feb; 79(2):167-74. doi: 10.1002/cyto.a.21015 PMID: 21265010
28. Cellerai C, Harari A, Vallelian F, Boyman O, Pantaleo G. Functional and phenotypic characterization of tetanus toxoid-specific human CD4+ T cells following re-immunization. Eur J Immunol. 2007 Apr; 37 (4):1129-38. PMID: 17372991
29. Pacheco SE, McIntosh K, Lu M, Mofenson LM, Diaz C, Foca M, et al. Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: An analysis of the women and infants transmission study. J Infect Dis. 2006 Oct 15; 194(8):1089-97. PMID: 16991083
30. Sallusto F, Lenig D, Förster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999 Oct 14; 401(6754):708-12. PMID: 10537110
31. Bradley LM, Haynes L, Swain SL. IL-7: maintaining T-cell memory and achieving homeostasis. Trends Immunol. 2005 Mar; 26(3):172-6. PMID: 15745860
32. Hockenbery D, Nuñez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 1990 Nov 22; 348(6299):334-6. PMID: 2250705
33. Soares AP, Kwong Chung CKC, Choice T, Hughes EJ, Jacobs G, van Rensburg EJ, et al. Longitudinal changes in CD4(+) T-cell memory responses induced by BCG vaccination of newborns. J Infect Dis. 2013 Apr; 207(7):1084-94. doi: 10.1093/infdis/jis941 PMID: 23293360
34. De Deus N, Moraleda C, Serna-Bolea C, Renom M, Menendez C, Naniche D. Impact of elevated maternal HIV viral load at delivery on T-cell populations in HIV exposed uninfected infants in Mozambique. BMC Infect Dis. 2015; 15(1):21-4.
35. Miles DJC, Gadama L, Gumbi A, Nyalo F, Makanani B, Heyderman RS. Human immunodeficiency virus (HIV) infection during pregnancy induces CD4 T-cell differentiation and modulates responses to Bacille Calmette-Guérin (BCG) vaccine in HIV-uninfected infants. Immunology. 2010 Mar; 129(3):446-54. doi: 10.1111/j.1365-2567.2009.03186.x PMID: 20002789
36. D'Arena G, Musto P, Cascavilla N, Di Giorgio G, Fusilli S, Zendoli F, et al. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features. Haematologica. 1998 Mar; 83(3):197-203. PMID: 9573672
37. Slyker JA, John-Stewart GC, Dong T, Lohman-Payne B, Reilly M, Atzberger A, et al. Phenotypic characterization of HIV-specific CD8+ T cells during early and chronic infant HIV-1 infection. PLoS One. 2011 Jan; 6(5):e20375. doi: 10.1371/journal.pone.0020375 PMID: 21655252
38. Venugopalan V, Thornton AC, Steinke DT, Rapp RP, Romanelli F, Feola DJ. Trimethoprim-sulfamethoxazole exposure alters ex vivo function of B lymphocytes isolated from human immunodeficiency virus-infected patients receiving Zidovudine. Pharmacotherapy. 2009 Apr; 29(4):373-82. doi: 10.1592/phco.29.4.373 PMID: 19323617
39. Miles DJC, van der Sande M, Jeffries D, Kaye S, Ismaili J, Ojuola O, et al. Cytomegalovirus infection in Gambian infants leads to profound CD8 T-cell differentiation. J Virol. 2007 Jun 1; 81(11):5766-76. PMID: 17376923
40. Miles DJC, van der Sande M, Jeffries D, Kaye S, Ojuola O, Sanneh M, et al. Maintenance of large subpopulations of differentiated CD8 T-cells two years after cytomegalovirus infection in Gambian infants. PLoS One. 2008 Jan; 3(8):e2905. doi: 10.1371/journal.pone.0002905 PMID: 18682836
41. Kolte L, Rosenfeldt V, Vang L, Jeppesen D, Karlsson I, Ryder LP, et al. Reduced thymic size but no evidence of impaired thymic function in uninfected children born to human immunodeficiency virusinfected mothers. Pediatr Infect Dis J. 2011 Apr; 30(4):325-30. doi: 10.1097/INF.0b013e3182019bc3 PMID: 21085050
42. Hanna-Wakim R, Yasukawa LL, Sung P, Fang M, Sullivan B, Rinki M, et al. Age-related increase in the frequency of CD4(+) T cells that produce interferon-gamma in response to staphylococcal enterotoxin B during childhood. J Infect Dis. 2009 Dec 15; 200(12):1921-7. doi: 10.1086/648375 PMID: 19909079
43. Kidzeru EB, Hesseling AC, Passmore J-AS, Myer L, Gamieldien H, Tchakoute CT, et al. In-utero exposure to maternal HIV infection alters T-cell immune responses to vaccination in HIV-uninfected infants. AIDS. 2014 Jun 19; 28(10):1421-30. doi: 10.1097/QAD.0000000000000292 PMID: 24785950
44. Mazzola TN, da Silva MTN, Abramczuk BM, Moreno YMF, Lima SCBS, Zorzeto TQ, et al. Impaired Bacillus Calmette-Guérin cellular immune response in HIV-exposed, uninfected infants. AIDS. 2011 Nov 13; 25(17):2079-87. doi: 10.1097/QAD.0b013e32834bba0a PMID: 21866040
45. Mansoor N, Scriba TJ, de Kock M, Tameris M, Abel B, Keyser A, et al. HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Guérin vaccine. J Infect Dis. 2009 Apr 1; 199(7):982-90. doi: 10.1086/597304 PMID: 19236280
46. Jones CE, Hesseling AC, Tena-Coki NG, Scriba TJ, Chegou NN, Kidd M, et al. The impact of HIV exposure and maternal Mycobacterium tuberculosis infection on infant immune responses to bacille Calmette-Guérin vaccination. AIDS. 2015 Jan 14; 29(2):155-65. doi: 10.1097/QAD.0000000000000536 PMID: 25535752
47. Elliott AM, Mawa PA, Webb EL, Nampijja M, Lyadda N, Bukusuba J, et al. Effects of maternal and infant co-infections, and of maternal immunisation, on the infant response to BCG and tetanus immunisation. Vaccine. 2010 Dec 16; 29(2):247-55. doi: 10.1016/j.vaccine.2010.10.047 PMID: 21040693
48. Gill TJ, Repetti CF, Metlay LA, Rabin BS, Taylor FH, Thompson DS, et al. Transplacental immunization of the human fetus to tetanus by immunization of the mother. J Clin Invest. 1983 Sep; 72(3):987-96. PMID: 6886013
49. Abramczuk BM, Mazzola TN, Moreno YM, Zorzeto TQ, Quintilio W, Wolf PS, et al. Impaired Humoral Response to Vaccines Among HIV-Exposed Uninfected Infants. Clin Vaccine Immunol. 2011; 18 (9):1406-9. doi: 10.1128/CVI.05065-11 PMID: 21775515
50. Soares AP, Scriba TJ, Joseph S, Harbacheuski R, Murray RA, Gelderbloem SJ, et al. Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles. J Immunol. 2008 Mar 1; 180(5):3569-77. PMID: 18292584
51. Tena-Coki NG, Scriba TJ, Peteni N, Eley B, Wilkinson RJ, Andersen P, et al. CD4 and CD8 T-cell responses to mycobacterial antigens in African children. Am J Respir Crit Care Med. 2010 Jul 1; 182 (1):120-9. doi: 10.1164/rccm.200912-1862OC PMID: 20224065
52. Kagina BMN, Abel B, Bowmaker M, Scriba TJ, Gelderbloem S, Smit E, et al. Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response. Vaccine. 2009 Sep 4; 27(40):5488-95. doi: 10.1016/j.vaccine.2009.06.103 PMID: 19616494
53. Longwe H, Phiri KS, Mbeye NM, Gondwe T, Jambo KC, Mandala WL. Proportions of CD4+, CD8+ and B cell subsets are not affected by exposure to HIV or to Cotrimoxazole prophylaxis in Malawian HIVuninfected but exposed children. BMC Immunol. 2015; 16(1):50.
54. Ota MO, O'Donovan D, Marchant A, Yamuah L, Harding E, Jaffar S, et al. HIV-negative infants born to HIV-1 but not HIV-2-positive mothers fail to develop a Bacillus Calmette-Guérin scar. AIDS. 1999 May 28; 13(8):996-8. PMID: 10371185
55. Van Rie A, Madhi SA, Heera JR, Meddows-Taylor S, Wendelboe AM, Anthony F, et al. Gamma interferon production in response to Mycobacterium bovis BCG and Mycobacterium tuberculosis antigens in infants born to human immunodeficiency virus-infected mothers. Clin Vaccine Immunol. 2006; 13 (2):246-52. PMID: 16467333